文献速递心律失常高血压

嗜铬细胞瘤中快速性心律失常的病理生理与急性管理

Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week.
PubMed 文献 · J Am Coll Cardiol · 2020-01-01

嗜铬细胞瘤释放儿茶酚胺可导致严重快速性心律失常。本文基于单中心近十年650例患者心电图回顾,总结儿茶酚胺诱导的快速性心律失常的病理生理与急性管理要点。

要点

  • 嗜铬细胞瘤可致严重难治性窦速、房颤及室速等快速性心律失常。
  • 此类心律失常源于儿茶酚胺过量而非原发性电生理基质,治疗需特殊考虑。
  • 理解儿茶酚胺合成释放及肾上腺素受体反应是优化管理的基础。

核心结论

  • 嗜铬细胞瘤释放儿茶酚胺可导致潜在致命的快速性心律失常,其治疗需基于对儿茶酚胺作用机制的理解。

研究设计与样本

  • 综述类文章,回顾性分析本机构近十年治疗的嗜铬细胞瘤患者(n=650)的心电图。

主要发现

  • 严重难治性窦性心动过速、心房颤动和室性心动过速是最常见或危及生命的儿茶酚胺诱导的快速性心律失常。

临床怎么用

  • 治疗需认识此类心律失常源于儿茶酚胺过量而非原发性电生理基质,需特殊考虑以避免并发症。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Pheochromocytomas, arising from chromaffin cells, produce catecholamines, epinephrine and norepinephrine. The tumor biochemical phenotype is defined by which of these exerts the greatest influence on the cardiovascular system when released into circulation in high amounts. Action on the heart and vasculature can cause potentially lethal arrhythmias, often in the setting of comorbid blood pressure derangements. In a review of electrocardiograms obtained on pheochromocytoma patients (n = 650) treated at our institution over the last decade, severe and refractory sinus tachycardia, atrial fibrillation, and ventricular tachycardia were found to be the most common or life-threatening catecholamine-induced tachyarrhythmias. These arrhythmias, arising from catecholamine excess rather than from a primary electrophysiologic substrate, require special considerations for treatment and complication avoidance. Understanding the synthesis and release of catecholamines, the adrenoceptors catecholamines bind to, and the cardiac and vascular response to epinephrine and norepinephrine underlies optimal management in catecholamine-induced tachyarrhythmias.

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Nazari MA, Rosenblum JS, Haigney MC, et al. Pathophysiology and Acute Management of Tachyarrhythmias in Pheochromocytoma: JACC Review Topic of the Week. J Am Coll Cardiol. 2020. PMID: 32703516. doi:10.1016/j.jacc.2020.04.080

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。